Skip to main content

1 Result(s)

within Mourad Tiab Remove this filter Biomedicine Remove this filter English Remove this filter Metabolic Diseases Remove this filter

and

  1. Article

    Open Access

    Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

    CD38-targeting immunotherapy is approved in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma (NDMM) that are transplant ineligible (TI) and is considered the be...

    Xavier Leleu, Cyrille Hulin, Jerome Lambert, Arthur Bobin, Aurore Perrot… in Nature Medicine (2024)

    Download PDF (3529 KB) View Article